Antibody-drug conjugates in triple-negative breast cancer (2010–2024): a bibliometric analysis of global trends and clinical translation
This study provides valuable insights into the current research status, recent advancements, and emerging trends in ADCs for TNBC, offering data support for the precise classification and treatment of TNBC.
Authors
- Shuhuang Xiang (ORCID: https://orcid.org/0000-0002-6727-6170)
- Shanghuo Li (ORCID: https://orcid.org/0000-0003-1275-5251)
- Xinyu Li (ORCID: https://orcid.org/0000-0002-4576-1474)
- Wenjun Xie (ORCID: https://orcid.org/0000-0001-8101-5519)
- Xiaoyi Wang (ORCID: https://orcid.org/0000-0001-5375-2706)
- Junyi Yang
- Xuedong Yin (ORCID: https://orcid.org/0009-0004-1188-1525)
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1007/s12672-025-03426-x
- Primary Topic
- HER2/EGFR in Cancer Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00